0.035162
0.000000
0.000000
0.000000
0.035162
0.000000
0.000000
0.000000
0.015142
0.00000
0.00000
0.00000
Loll, P.J.
Kaplan, J.
Selinsky, B.
Axelsen, P.H.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
16
90.00
90.00
90.00
28.440
28.440
66.040
C8 H9 N O4
183.161
(2S)-amino(3,5-dihydroxyphenyl)ethanoic acid
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C6 H12 O6
180.156
beta-D-glucopyranose
beta-D-glucose; D-glucose; glucose
D-saccharide, beta linking
Cl -1
35.453
CHLORIDE ION
non-polymer
C8 H9 N O3
167.162
(2R)-amino(4-hydroxyphenyl)ethanoic acid
D-peptide linking
H2 O
18.015
WATER
non-polymer
C3 H6 O3
90.078
LACTIC ACID
non-polymer
C7 H15 N O2
145.199
N-methyl-D-leucine
D-peptide linking
C9 H10 Cl N O4
231.633
n
(betaR)-3-chloro-beta-hydroxy-L-tyrosine
L-peptide linking
C9 H10 Cl N O4
231.633
(betaR)-3-CHLORO-BETA-HYDROXY-D-TYROSINE
D-peptide linking
C7 H15 N O3
161.199
vancosamine
(1R,3S,4S,5S)-3-amino-2,3,6-trideoxy-3-methyl-alpha-L-arabino-hexopyranose
L-saccharide, alpha linking
N
1
N
N
N
2
N
O
Y
3
N
C
Y
4
N
C
Y
5
N
C
Y
6
N
C
N
7
N
O
Y
8
N
C
Y
9
N
C
N
10
S
C
N
11
N
C
N
12
N
O
N
13
N
O
N
14
N
H
N
15
N
H
N
16
N
H
N
17
N
H
N
18
N
H
N
19
N
H
N
20
N
H
N
21
N
H
N
22
N
H
N
23
N
N
N
24
S
C
N
25
N
C
N
26
N
O
N
27
N
C
N
28
N
C
N
29
N
O
N
30
N
N
N
31
N
O
N
32
N
H
N
33
N
H
N
34
N
H
N
35
N
H
N
36
N
H
N
37
N
H
N
38
N
H
N
39
N
H
N
40
R
C
N
41
S
C
N
42
S
C
N
43
R
C
N
44
N
C
N
45
R
C
N
46
N
O
N
47
N
O
N
48
N
O
N
49
N
O
N
50
N
O
N
51
N
O
N
52
N
H
N
53
N
H
N
54
N
H
N
55
N
H
N
56
N
H
N
57
N
H
N
58
N
H
N
59
N
H
N
60
N
H
N
61
N
H
N
62
N
H
N
63
N
H
N
64
N
CL
N
65
N
N
N
66
R
C
N
67
N
C
N
68
N
O
N
69
N
O
Y
70
N
C
Y
71
N
C
Y
72
N
C
Y
73
N
C
N
74
N
O
Y
75
N
C
Y
76
N
C
N
77
N
H
N
78
N
H
N
79
N
H
N
80
N
H
N
81
N
H
N
82
N
H
N
83
N
H
N
84
N
H
N
85
N
H
N
86
N
O
N
87
N
H
N
88
N
H
N
89
N
C
N
90
R
C
N
91
N
C
N
92
N
O
N
93
N
O
N
94
N
O
N
95
N
H
N
96
N
H
N
97
N
H
N
98
N
H
N
99
N
H
N
100
N
H
N
101
N
N
N
102
N
C
N
103
R
C
N
104
N
C
N
105
N
O
N
106
N
C
N
107
N
C
N
108
N
C
N
109
N
C
N
110
N
O
N
111
N
H
N
112
N
H
N
113
N
H
N
114
N
H
N
115
N
H
N
116
N
H
N
117
N
H
N
118
N
H
N
119
N
H
N
120
N
H
N
121
N
H
N
122
N
H
N
123
N
H
N
124
N
H
N
125
N
H
N
126
N
N
N
127
S
C
N
128
N
O
Y
129
N
C
Y
130
N
C
Y
131
N
C
Y
132
N
C
Y
133
N
C
Y
134
N
C
N
135
R
C
N
136
N
CL
N
137
N
O
N
138
N
C
N
139
N
O
N
140
N
O
N
141
N
H
N
142
N
H
N
143
N
H
N
144
N
H
N
145
N
H
N
146
N
H
N
147
N
H
N
148
N
H
N
149
N
H
N
150
N
H
N
151
N
N
N
152
R
C
N
153
N
C
N
154
N
O
N
155
N
O
N
156
R
C
N
157
N
O
Y
158
N
C
Y
159
N
C
Y
160
N
C
Y
161
N
C
N
162
N
CL
Y
163
N
C
Y
164
N
C
N
165
N
O
N
166
N
H
N
167
N
H
N
168
N
H
N
169
N
H
N
170
N
H
N
171
N
H
N
172
N
H
N
173
N
H
N
174
N
H
N
175
N
H
N
176
R
C
N
177
N
C
N
178
S
C
N
179
N
N
N
180
N
C
N
181
S
C
N
182
N
O
N
183
S
C
N
184
N
O
N
185
N
C
N
186
N
O
N
187
N
H
N
188
N
H
N
189
N
H
N
190
N
H
N
191
N
H
N
192
N
H
N
193
N
H
N
194
N
H
N
195
N
H
N
196
N
H
N
197
N
H
N
198
N
H
N
199
N
H
N
200
N
H
N
201
N
H
N
1
N
sing
N
2
N
sing
Y
3
N
sing
Y
4
N
doub
Y
5
N
doub
Y
6
N
sing
N
7
N
sing
Y
8
N
doub
Y
9
N
sing
N
10
N
sing
N
11
N
sing
N
12
N
doub
N
13
N
sing
N
14
N
sing
N
15
N
sing
N
16
N
sing
N
17
N
sing
N
18
N
sing
N
19
N
sing
N
20
N
sing
N
21
N
sing
N
22
N
sing
N
23
N
sing
N
24
N
sing
N
25
N
sing
N
26
N
sing
N
27
N
sing
N
28
N
sing
N
29
N
doub
N
30
N
sing
N
31
N
sing
N
32
N
sing
N
33
N
sing
N
34
N
doub
N
35
N
sing
N
36
N
sing
N
37
N
sing
N
38
N
sing
N
39
N
sing
N
40
N
sing
N
41
N
sing
N
42
N
sing
N
43
N
sing
N
44
N
sing
N
45
N
sing
N
46
N
sing
N
47
N
sing
N
48
N
sing
N
49
N
sing
N
50
N
sing
N
51
N
sing
N
52
N
sing
N
53
N
sing
N
54
N
sing
N
55
N
sing
N
56
N
sing
N
57
N
sing
N
58
N
sing
N
59
N
sing
N
60
N
sing
N
61
N
sing
N
62
N
sing
N
63
N
sing
N
64
N
sing
N
65
N
sing
N
66
N
sing
N
67
N
sing
N
68
N
sing
N
69
N
doub
N
70
N
sing
N
71
N
sing
Y
72
N
doub
Y
73
N
sing
Y
74
N
sing
N
75
N
sing
Y
76
N
doub
N
77
N
sing
N
78
N
sing
Y
79
N
sing
N
80
N
sing
Y
81
N
doub
N
82
N
sing
N
83
N
sing
N
84
N
sing
N
85
N
sing
N
86
N
sing
N
87
N
doub
N
88
N
sing
N
89
N
sing
N
90
N
sing
N
91
N
sing
N
92
N
sing
N
93
N
sing
N
94
N
sing
N
95
N
sing
N
96
N
sing
N
97
N
sing
N
98
N
sing
N
99
N
sing
N
100
N
sing
N
101
N
doub
N
102
N
sing
N
103
N
sing
N
104
N
sing
N
105
N
sing
N
106
N
sing
N
107
N
sing
N
108
N
sing
N
109
N
sing
N
110
N
sing
N
111
N
sing
N
112
N
sing
N
113
N
sing
N
114
N
sing
N
115
N
sing
N
116
N
sing
N
117
N
sing
N
118
N
sing
N
119
N
sing
N
120
N
sing
N
121
N
sing
N
122
N
sing
Y
123
N
sing
Y
124
N
doub
Y
125
N
doub
Y
126
N
sing
Y
127
N
doub
N
128
N
sing
Y
129
N
sing
N
130
N
sing
N
131
N
doub
N
132
N
sing
N
133
N
sing
N
134
N
sing
N
135
N
sing
N
136
N
sing
N
137
N
sing
N
138
N
sing
N
139
N
sing
N
140
N
sing
N
141
N
sing
N
142
N
sing
N
143
N
sing
N
144
N
sing
N
145
N
sing
N
146
N
sing
N
147
N
sing
N
148
N
sing
N
149
N
doub
N
150
N
sing
N
151
N
sing
N
152
N
sing
N
153
N
sing
Y
154
N
doub
Y
155
N
sing
Y
156
N
sing
Y
157
N
doub
Y
158
N
doub
Y
159
N
sing
N
160
N
sing
N
161
N
sing
N
162
N
sing
N
163
N
sing
N
164
N
sing
N
165
N
sing
N
166
N
sing
N
167
N
sing
N
168
N
sing
N
169
N
sing
N
170
N
sing
N
171
N
sing
N
172
N
sing
N
173
N
sing
N
174
N
sing
N
175
N
sing
N
176
N
sing
N
177
N
sing
N
178
N
sing
N
179
N
sing
N
180
N
sing
N
181
N
sing
N
182
N
sing
N
183
N
sing
N
184
N
sing
N
185
N
sing
N
186
N
sing
N
187
N
sing
N
188
N
sing
N
189
N
sing
N
190
N
sing
N
191
N
sing
N
192
N
sing
N
193
N
sing
N
194
N
sing
N
195
N
sing
N
196
N
sing
US
J.Med.Chem.
JMCMAR
0151
0022-2623
42
4714
10.1021/JM990361T
10579833
Vancomycin Binding to Low-Affinity Ligands: Delineating a Minimum Set of Interactions Necessary for High-Affinity Binding.
1999
10.2210/pdb1c0r/pdb
pdb_00001c0r
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100
1
CCD
1996-09-20
CUSTOM-MADE
SINGLE WAVELENGTH
M
x-ray
1
0.918
1.0
A1
CHESS
0.918
SYNCHROTRON
CHESS BEAMLINE A1
1149.977
VANCOMYCIN
2
man
polymer
323.340
vancosamine-(1-2)-beta-D-glucopyranose
2
man
branched
35.453
CHLORIDE ION
3
syn
non-polymer
90.078
LACTIC ACID
1
syn
non-polymer
18.015
water
45
nat
water
no
yes
(MLU)(OMZ)N(GHP)(GHP)(OMY)(3FG)
XXNGGYX
A,B
polypeptide(L)
n
n
n
n
n
n
n
sample
31958
AMYCOLATOPSIS ORIENTALIS
1
2.90
57.63
4.6
SODIUM CHLORIDE, LACTIC ACID, PH 4.6, VAPOR DIFFUSION/HANGING DROP, TEMPERATURE 291K
atom_site
chem_comp
entity
entity_poly
pdbx_branch_scheme
pdbx_chem_comp_identifier
pdbx_entity_branch
pdbx_entity_branch_descriptor
pdbx_entity_branch_link
pdbx_entity_branch_list
pdbx_entity_nonpoly
pdbx_molecule
pdbx_nonpoly_scheme
pdbx_struct_assembly
pdbx_struct_assembly_gen
pdbx_struct_special_symmetry
pdbx_validate_close_contact
software
struct_asym
struct_conn
struct_site
struct_site_gen
atom_site
chem_comp
chem_comp_atom
chem_comp_bond
database_2
struct_conn
repository
Initial release
Carbohydrate remediation
repository
Remediation
Version format compliance
Version format compliance
Atomic model
Database references
Derived calculations
Non-polymer description
Structure summary
Other
Advisory
Atomic model
Data collection
Derived calculations
Polymer sequence
Refinement description
Structure summary
Atomic model
Data collection
Database references
Derived calculations
Structure summary
1
0
1999-07-30
1
1
2011-06-14
1
2
2011-07-13
1
3
2011-07-27
1
4
2012-12-12
2
0
2020-07-29
3
0
2023-11-15
_atom_site.B_iso_or_equiv
_atom_site.Cartn_x
_atom_site.Cartn_y
_atom_site.Cartn_z
_atom_site.auth_asym_id
_atom_site.auth_atom_id
_atom_site.auth_comp_id
_atom_site.auth_seq_id
_atom_site.label_alt_id
_atom_site.label_asym_id
_atom_site.label_atom_id
_atom_site.label_comp_id
_atom_site.label_entity_id
_atom_site.occupancy
_atom_site.type_symbol
_chem_comp.name
_chem_comp.type
_entity_poly.pdbx_seq_one_letter_code_can
_pdbx_struct_assembly.method_details
_pdbx_struct_assembly_gen.asym_id_list
_pdbx_struct_special_symmetry.label_asym_id
_pdbx_validate_close_contact.auth_asym_id_1
_pdbx_validate_close_contact.auth_asym_id_2
_pdbx_validate_close_contact.auth_seq_id_1
_pdbx_validate_close_contact.auth_seq_id_2
_struct_conn.pdbx_dist_value
_struct_conn.pdbx_leaving_atom_flag
_struct_conn.pdbx_ptnr1_label_alt_id
_struct_conn.pdbx_ptnr2_label_alt_id
_struct_conn.ptnr1_auth_asym_id
_struct_conn.ptnr1_auth_comp_id
_struct_conn.ptnr1_auth_seq_id
_struct_conn.ptnr1_label_asym_id
_struct_conn.ptnr1_label_atom_id
_struct_conn.ptnr1_label_comp_id
_struct_conn.ptnr1_label_seq_id
_struct_conn.ptnr2_auth_asym_id
_struct_conn.ptnr2_auth_comp_id
_struct_conn.ptnr2_auth_seq_id
_struct_conn.ptnr2_label_asym_id
_struct_conn.ptnr2_label_atom_id
_struct_conn.ptnr2_label_comp_id
_struct_conn.ptnr2_label_seq_id
_atom_site.auth_atom_id
_atom_site.label_atom_id
_chem_comp.pdbx_synonyms
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_conn.pdbx_leaving_atom_flag
A
BGC
8
n
C
BGC
1
A
RER
9
n
C
RER
2
B
BGC
8
n
D
BGC
1
B
RER
9
n
D
RER
2
DGlcpb
b-D-glucopyranose
b-D-Glcp
Glc
CRYSTAL STRUCTURE OF VANCOMYCIN
CRYSTAL STRUCTURE OF VANCOMYCIN COMPLEXED WITH 2-ACETOXY-D-PROPANOIC ACID
CRYSTAL STRUCTURE OF VANCOMYCIN COMPLEXED WITH DI-ACETYL-LYS-D-ALA-D-ALA
SOLUTION STRUCTURE OF A82846B COMPLEXED WITH ITS CELL WALL PENTAPEPTIDE FRAGMENT
CRYSTAL STRUCTURE OF VANCOMYCIN AGLYCON
CRYSTAL STRUCTURE OF TDP-EPI-VANCOSAMINYLTRANSFERASE GTFA COMPLEXD WITH TDP AND DESVANCOSAMINYL VANCOMYCIN
CRYSTAL STRUCTURE OF TDP-EPI-VANCOSAMINYLTRANSFERASE GTFA COMPLEXED WITH TDP AND VANCOMYCIN
CRYSTAL STRUCTURE OF VANCOMYCIN COMPLEXED WITH N-ACETYL GLYCIN
CRYSTAL STRUCTURE OF TDP-VANCOSAMINYLTRANSFERASE GTFD COMPLEXED WITH TDP AND DESVANCOSAMINYL VANCOMYCIN.
CRYSTAL STRUCTURE OF VANCOMYCIN
RCSB
Y
RCSB
1999-07-20
REL
oligosaccharide
WURCS=2.0/2,2,1/[a2122h-1b_1-5][ad621m-1a_1-5_3*C_3*N]/1-2/a2-b1
2
PDB2Glycan
1.1.0
WURCS
[][D-1-deoxy-Glcp]{[(2+1)][a-L-2-deoxy-Fucp3N]{}}
2
PDB-CARE
LINUCS
C1
O2
RER
BGC
2
1
2
O1
HO2
sing
n
n
CL
CHLORIDE ION
LAC
LACTIC ACID
HOH
water
VANCOMYCIN IS A TRICYCLIC GLYCOPEPTIDE. THE SCAFFOLD IS
A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L-L. IT IS
FURTHER GLYCOSYLATED BY A DISACCHARIDE MADE OF D-GLUCOSE
AND VANCOSAMINE.
HERE, VANCOMYCIN IS REPRESENTED BY GROUPING TOUGHER THE
SEQUENCE (SEQRES) AND THE TWO LIGANDS (HET) BGC AND RER.
Antibiotic
VANCOMYCIN IS A TRICYCLIC GLYCOPEPTIDE,
GLYCOSYLATED BY A DISACCHARIDE (RESIDUES 8
AND 9) ON RESIDUE 4.
VANCOMYCIN
Glycopeptide
CL
20
3
CL
CL
20
A
CL
21
3
CL
CL
21
A
CL
22
3
CL
CL
22
B
LAC
23
4
LAC
LAC
23
B
HOH
2001
5
HOH
HOH
2001
A
HOH
2002
5
HOH
HOH
2002
A
HOH
2003
5
HOH
HOH
2003
A
HOH
2004
5
HOH
HOH
2004
A
HOH
2005
5
HOH
HOH
2005
A
HOH
2006
5
HOH
HOH
2006
A
HOH
2007
5
HOH
HOH
2007
A
HOH
2008
5
HOH
HOH
2008
A
HOH
2009
5
HOH
HOH
2009
A
HOH
2010
5
HOH
HOH
2010
A
HOH
2011
5
HOH
HOH
2011
A
HOH
2012
5
HOH
HOH
2012
A
HOH
2013
5
HOH
HOH
2013
A
HOH
2014
5
HOH
HOH
2014
A
HOH
2015
5
HOH
HOH
2015
A
HOH
2016
5
HOH
HOH
2016
A
HOH
2017
5
HOH
HOH
2017
A
HOH
2018
5
HOH
HOH
2018
A
HOH
2019
5
HOH
HOH
2019
A
HOH
2020
5
HOH
HOH
2020
A
HOH
2021
5
HOH
HOH
2021
A
HOH
2022
5
HOH
HOH
2022
A
HOH
2023
5
HOH
HOH
2023
A
HOH
2024
5
HOH
HOH
2024
A
HOH
2025
5
HOH
HOH
2025
A
HOH
2001
5
HOH
HOH
2001
B
HOH
2002
5
HOH
HOH
2002
B
HOH
2003
5
HOH
HOH
2003
B
HOH
2004
5
HOH
HOH
2004
B
HOH
2005
5
HOH
HOH
2005
B
HOH
2006
5
HOH
HOH
2006
B
HOH
2007
5
HOH
HOH
2007
B
HOH
2008
5
HOH
HOH
2008
B
HOH
2009
5
HOH
HOH
2009
B
HOH
2010
5
HOH
HOH
2010
B
HOH
2011
5
HOH
HOH
2011
B
HOH
2012
5
HOH
HOH
2012
B
HOH
2013
5
HOH
HOH
2013
B
HOH
2014
5
HOH
HOH
2014
B
HOH
2015
5
HOH
HOH
2015
B
HOH
2016
5
HOH
HOH
2016
B
HOH
2017
5
HOH
HOH
2017
B
HOH
2018
5
HOH
HOH
2018
B
HOH
2019
5
HOH
HOH
2019
B
HOH
2020
5
HOH
HOH
2020
B
MLU
1
n
1
MLU
1
A
OMZ
2
n
2
OMZ
2
A
ASN
3
n
3
ASN
3
A
GHP
4
n
4
GHP
4
A
GHP
5
n
5
GHP
5
A
OMY
6
n
6
OMY
6
A
3FG
7
n
7
3FG
7
A
MLU
1
n
1
MLU
1
B
OMZ
2
n
2
OMZ
2
B
ASN
3
n
3
ASN
3
B
GHP
4
n
4
GHP
4
B
GHP
5
n
5
GHP
5
B
OMY
6
n
6
OMY
6
B
3FG
7
n
7
3FG
7
B
0.114
0.142
934
software_defined_assembly
PISA
4
tetrameric
4170
-68.4
3680
0.0000000000
1.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
4_455
y-1/2,-x+1/2,z+1/4
crystal symmetry operation
-14.2200000000
14.2200000000
16.5100000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
6_455
x-1/2,-y+1/2,-z+1/4
crystal symmetry operation
-14.2200000000
14.2200000000
16.5100000000
0.0000000000
-1.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
8_555
-y,-x,-z+1/2
crystal symmetry operation
0.0000000000
0.0000000000
33.0200000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
HOH
2012
I
HOH
1
D
D
O2
O5
BGC
RER
1
2
2.02
B
1
D
D
C2
C1
BGC
RER
1
2
2.15
B
1
A
ASN
3
-100.24
-68.57
REFINEMENT WAS CARRIED OUT AGAINST F -SQUARED USING SHELXL-93. MOLECULAR GEOMETRY AND ATOMIC DISPLACEMENT PARAMETERS WERE RESTRAINED THROUGHOUT. INDEPENDENT VANCOMYCIN MONOMERS WERE RESTRAINED TO HAVE SIMILAR 1-2 AND 1-3 DISTANCES; RESTRAINTS WERE ALSO IMPOSED TO LIMIT DEVIATIONS FROM PLANARITY IN RINGS AND SP2 SYSTEMS. ALONG-BOND COMPONENTS OF ANISOTROPIC DISPLACEMENT PARAMETERS WERE SUBJECTED TO RESTRAINTS. SOLVENT WATER ATOMS WERE RESTRAINED TO BE APPROXIMATELY ISOTROPIC AND WERE MADE SUBJECT TO ANTI-BUMPING RESTRAINTS. CONJUGATE GRADIENT REFINEMENT WAS USED THROUGHOUT, EXCEPT AT THE LAST STAGES, WHEN BLOCKED LEAST SQUARES WAS USED.
0.142
0.114
1.00
20.00
934
14301
97.0
RANDOM
1
THROUGHOUT
0.000
ENGH & HUBER
1.00
20.00
45
256
51
0
160
0.019
1.000
20.000
1C0R
13896
2.000
0.05200
1
29.8000
16.400
97.0
0.06500
1.00
1.04
1
1.90
54.0
refinement
SHELXL
data reduction
DENZO
data scaling
SCALEPACK
COMPLEX OF VANCOMYCIN WITH D-LACTIC ACID
1
N
N
1
N
N
2
N
N
2
N
N
3
N
N
3
N
N
3
N
N
4
N
N
5
N
N
5
N
N
covale
1.364
both
A
MLU
1
A
C
MLU
1
1_555
A
OMZ
2
A
N
OMZ
2
1_555
covale
1.324
both
A
OMZ
2
A
C
OMZ
2
1_555
A
ASN
3
A
N
ASN
3
1_555
covale
1.400
none
A
OMZ
2
A
OH
OMZ
2
1_555
A
GHP
4
A
C5
GHP
4
1_555
covale
1.337
both
A
ASN
3
A
C
ASN
3
1_555
A
GHP
4
A
N
GHP
4
1_555
covale
1.349
both
A
GHP
4
A
C
GHP
4
1_555
A
GHP
5
A
N
GHP
5
1_555
covale
1.383
none
A
GHP
4
A
C3
GHP
4
1_555
A
OMY
6
A
OCZ
OMY
6
1_555
covale
1.427
one
A
GHP
4
A
O4
GHP
4
1_555
C
BGC
1
C
C1
BGC
1_555
covale
1.332
both
A
GHP
5
A
C
GHP
5
1_555
A
OMY
6
A
N
OMY
6
1_555
covale
1.470
one
A
GHP
5
A
C3
GHP
5
1_555
A
3FG
7
A
CG1
3FG
7
1_555
covale
1.326
both
A
OMY
6
A
C
OMY
6
1_555
A
3FG
7
A
N
3FG
7
1_555
covale
1.340
both
B
MLU
1
B
C
MLU
1
1_555
B
OMZ
2
B
N
OMZ
2
1_555
covale
1.321
both
B
OMZ
2
B
C
OMZ
2
1_555
B
ASN
3
B
N
ASN
3
1_555
covale
1.392
none
B
OMZ
2
B
OH
OMZ
2
1_555
B
GHP
4
B
C5
GHP
4
1_555
covale
1.339
both
B
ASN
3
B
C
ASN
3
1_555
B
GHP
4
B
N
GHP
4
1_555
covale
1.338
both
B
GHP
4
B
C
GHP
4
1_555
B
GHP
5
B
N
GHP
5
1_555
covale
1.369
none
B
GHP
4
B
C3
GHP
4
1_555
B
OMY
6
B
OCZ
OMY
6
1_555
covale
1.432
one
B
B
B
GHP
4
B
O4
GHP
4
1_555
D
BGC
1
D
C1
BGC
1_555
covale
1.434
one
A
A
B
GHP
4
B
O4
GHP
4
1_555
D
BGC
1
D
C1
BGC
1_555
covale
1.325
both
B
GHP
5
B
C
GHP
5
1_555
B
OMY
6
B
N
OMY
6
1_555
covale
1.482
one
B
GHP
5
B
C3
GHP
5
1_555
B
3FG
7
B
CG1
3FG
7
1_555
covale
1.326
both
B
OMY
6
B
C
OMY
6
1_555
B
3FG
7
B
N
3FG
7
1_555
covale
1.425
both
C
BGC
1
C
O2
BGC
1_555
C
RER
2
C
C1
RER
1_555
covale
1.113
both
B
D
BGC
1
D
O2
BGC
1_555
D
RER
2
D
C1
RER
1_555
covale
1.477
both
A
D
BGC
1
D
O2
BGC
1_555
D
RER
2
D
C1
RER
1_555
ANTIBIOTIC
ANTIBIOTIC, GLYCOPEPTIDE ANTIBIOTIC
A
GHP
5
A
GHP
5
1
A
OMY
6
A
OMY
6
6.16
B
GHP
5
B
GHP
5
1
B
OMY
6
B
OMY
6
19.74
NOR00681
NOR
1
NOR00681
1
7
1C0R
1
7
NOR00681
A
1
1
7
1
7
1C0R
1
7
NOR00681
B
1
1
7
96
P 43 21 2